Raydium Price Prediction: Can $RAY Extend Its 55% Rally?
Raydium has gone from quiet sideways trading to a sharp, sustained climb, and the move is now testing how much room buyers still have. Momentum, derivatives activity, and protocol revenue are
All CryptoCompass stories in one scan-friendly feed: breaking crypto news, market analysis, policy shifts, on-chain research, and practical explainers.
Raydium has gone from quiet sideways trading to a sharp, sustained climb, and the move is now testing how much room buyers still have. Momentum, derivatives activity, and protocol revenue are

A failed XRP purchase by Crypto Enthusiast Digital Outlook’s son has raised questions about how some exchanges handle XRP availability. Caleb tried to buy XRP on a major Canadian exchange, bu

Altcoin RENDER breaks out of critical resistance level. However, now it faces another at $1.77. Can the price of RENDER continue to pump this month? The altcoin crypto community is thrilled a
Why Is Crypto Market Down Today: Why BTC, ETH, XRP Turns Red? Red candles are all over your screen today, and no, you're not imagining it. Why is crypto market down today? In short: bond yiel

Bitcoin’s recovery has brought its price back to a level that could decide how 2026 ends. BTC climbed above $83,000 after spending much of the year below it, but the next test matters just as
OpenAI made Daybreak, its AI system for detecting and fixing software flaws, available to the Ukrainian government for free. The target is defending hospitals, power plants, and telecom netwo

Bitcoin, Ethereum ve diğer büyük kripto paraların teknik görünümü ile ABD hisse senetleri arasında dikkat çekici bir ayrışma ortaya çıktı. Analist Scott Melker tarafından paylaşılan verilere

Key Takeaways Seven banks joined shared tokenised-deposit infrastructure. Live sterling funded two completed remortgages. Marketplace money moved, but goods were simulated. Deposits remained
TLDR MGM Resorts shares plunged 8% to $34.69 during Thursday’s premarket session. People Inc., led by Barry Diller, abandoned its $48.30-per-share acquisition proposal. Despite withdrawing th
Key Takeaways The FDA advisory committee delivered a 7-2 vote indicating Grail’s Galleri test benefits exceed potential risks. Safety received unanimous approval (10-0), while effectiveness p